BioCentury | Jan 28, 2020
Distillery Therapeutics

Inhibiting CD36 to overcome resistance to Tykerb in HER2-positive breast cancer

...Manabu Kurokawa, Dartmouth College, Hanover, N.H.; Kent State University, Kent, Ohio email: mkurokaw@kent.edu Claire Quang Tykerb, Tyverb, lapatinib (GW572016) Dartmouth College CD36...
BioCentury | Dec 6, 2019
Targets & Mechanisms

A view of immune reprogramming from ASH

...protect MM cells from chemotherapy-induced apoptosis in culture ( No. 3086 ). A group from Dartmouth College...
...Jakavi (Other), Jakafi (Other) pevonedistat (MLN4924, TAK-924) American Society of Hematology Takeda Pharmaceutical Co. Ltd. Fudan University National Institutes of Health Dartmouth College Medical...
BioCentury | Nov 16, 2018
Tools & Techniques

Benchtop manufacturing gets smaller

...an innovative yeast-based protein production platform that could control protein glycosylation. GlycoFi launched out of Dartmouth College...
...boosters for vaccines, for example.” Companies and Institutions Mentioned Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Dartmouth College...
BioCentury | Nov 15, 2018
Tools & Techniques

Benchtop manufacturing gets smaller

...an innovative yeast-based protein production platform that could control protein glycosylation. GlycoFi launched out of Dartmouth College...
...boosters for vaccines, for example.” Companies and Institutions Mentioned Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Dartmouth College...
BioCentury | Aug 24, 2018
Targets & Mechanisms

Computing checkpoints

...ITIM domains VISTA - V-region immunoglobulin-containing suppressor of T cell activation Michael Leviten, Senior Writer Bayer AG Compugen Ltd. Dartmouth College ImmuNext...
BioCentury | Feb 23, 2018
Emerging Company Profile

Cutting viruses

...Thomas Malcolm, Rob Simmons and David Rowe University collaborators: Temple University, University of California Berkeley, Dartmouth College...
BioCentury | Oct 6, 2017
Clinical News

Celyad’s CAR T leads to leukemia-free state in AML patient

...KLRK1; CD314). Celyad is developing CYAD-01 in partnership with Celdara Medical LLC (Lebanon, N.H.) and Dartmouth College...
...Aug. 10 ). Celdara Medical LLC , Lebanon, N.H. Celyad S.A. (Euronext:CYAD; NASDAQ:CYAD), Mont-Saint-Guibert, Belgium Dartmouth College...
BioCentury | Sep 19, 2017
Distillery Therapeutics

Infectious disease

...published online Aug. 14, 2017 doi:10.1073/pnas.1707304114 CONTACT: Nianshuang Wang, Geisel School of Medicine at Dartmouth College...
...email: Jason.S.McLellan@Dartmouth.edu CONTACT: Andrew B. Ward, The Scripps Research Institute, La Jolla, Calif. email: andrew@scripps.edu Hongjiang Li Dartmouth College The...
BioCentury | Aug 10, 2017
Company News

Celyad amends CAR T deal

...from chimeric antigen receptor (CAR) T assets partnered with Celdara Medical LLC (Lebanon, N.H.) and Dartmouth College...
...CAR-T NKR-2, two other autologous CAR T cell therapies and an allogeneic T cell platform. Dartmouth College...
...the amended Celdara deal (see BioCentury, May 8 ). Celdara Medical LLC , Lebanon, N.H. Dartmouth College...
BioCentury | Aug 4, 2017
Company News

Celyad gains on CAR T deal amendment

...from chimeric antigen receptor (CAR) T assets partnered with Celdara Medical LLC (Lebanon, N.H.) and Dartmouth College...
...CAR-T NKR-2, two other autologous CAR T cell therapies and an allogeneic T cell platform. Dartmouth College...
...of the amended Celdara deal (see BioCentury Extra, May 2) . Chris Lieu CAR-T NKR-2 Celdara Medical LLC Celyad S.A. Dartmouth College Killer...
Items per page:
1 - 10 of 31
BioCentury | Jan 28, 2020
Distillery Therapeutics

Inhibiting CD36 to overcome resistance to Tykerb in HER2-positive breast cancer

...Manabu Kurokawa, Dartmouth College, Hanover, N.H.; Kent State University, Kent, Ohio email: mkurokaw@kent.edu Claire Quang Tykerb, Tyverb, lapatinib (GW572016) Dartmouth College CD36...
BioCentury | Dec 6, 2019
Targets & Mechanisms

A view of immune reprogramming from ASH

...protect MM cells from chemotherapy-induced apoptosis in culture ( No. 3086 ). A group from Dartmouth College...
...Jakavi (Other), Jakafi (Other) pevonedistat (MLN4924, TAK-924) American Society of Hematology Takeda Pharmaceutical Co. Ltd. Fudan University National Institutes of Health Dartmouth College Medical...
BioCentury | Nov 16, 2018
Tools & Techniques

Benchtop manufacturing gets smaller

...an innovative yeast-based protein production platform that could control protein glycosylation. GlycoFi launched out of Dartmouth College...
...boosters for vaccines, for example.” Companies and Institutions Mentioned Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Dartmouth College...
BioCentury | Nov 15, 2018
Tools & Techniques

Benchtop manufacturing gets smaller

...an innovative yeast-based protein production platform that could control protein glycosylation. GlycoFi launched out of Dartmouth College...
...boosters for vaccines, for example.” Companies and Institutions Mentioned Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Dartmouth College...
BioCentury | Aug 24, 2018
Targets & Mechanisms

Computing checkpoints

...ITIM domains VISTA - V-region immunoglobulin-containing suppressor of T cell activation Michael Leviten, Senior Writer Bayer AG Compugen Ltd. Dartmouth College ImmuNext...
BioCentury | Feb 23, 2018
Emerging Company Profile

Cutting viruses

...Thomas Malcolm, Rob Simmons and David Rowe University collaborators: Temple University, University of California Berkeley, Dartmouth College...
BioCentury | Oct 6, 2017
Clinical News

Celyad’s CAR T leads to leukemia-free state in AML patient

...KLRK1; CD314). Celyad is developing CYAD-01 in partnership with Celdara Medical LLC (Lebanon, N.H.) and Dartmouth College...
...Aug. 10 ). Celdara Medical LLC , Lebanon, N.H. Celyad S.A. (Euronext:CYAD; NASDAQ:CYAD), Mont-Saint-Guibert, Belgium Dartmouth College...
BioCentury | Sep 19, 2017
Distillery Therapeutics

Infectious disease

...published online Aug. 14, 2017 doi:10.1073/pnas.1707304114 CONTACT: Nianshuang Wang, Geisel School of Medicine at Dartmouth College...
...email: Jason.S.McLellan@Dartmouth.edu CONTACT: Andrew B. Ward, The Scripps Research Institute, La Jolla, Calif. email: andrew@scripps.edu Hongjiang Li Dartmouth College The...
BioCentury | Aug 10, 2017
Company News

Celyad amends CAR T deal

...from chimeric antigen receptor (CAR) T assets partnered with Celdara Medical LLC (Lebanon, N.H.) and Dartmouth College...
...CAR-T NKR-2, two other autologous CAR T cell therapies and an allogeneic T cell platform. Dartmouth College...
...the amended Celdara deal (see BioCentury, May 8 ). Celdara Medical LLC , Lebanon, N.H. Dartmouth College...
BioCentury | Aug 4, 2017
Company News

Celyad gains on CAR T deal amendment

...from chimeric antigen receptor (CAR) T assets partnered with Celdara Medical LLC (Lebanon, N.H.) and Dartmouth College...
...CAR-T NKR-2, two other autologous CAR T cell therapies and an allogeneic T cell platform. Dartmouth College...
...of the amended Celdara deal (see BioCentury Extra, May 2) . Chris Lieu CAR-T NKR-2 Celdara Medical LLC Celyad S.A. Dartmouth College Killer...
Items per page:
1 - 10 of 31